This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Royal Philips (PHG) is a Top Value Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Philips Q2 Earnings and Revenues Decline Year Over Year, Shares Fall
by Zacks Equity Research
PHG's second-quarter 2025 earnings and revenues decline year over year, with macro headwinds and tariffs weighing on the stock.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Royal Philips (PHG) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
GE HealthCare's Flyrcado Sets New Benchmark in Cardiac PET Imaging
by Zacks Equity Research
GEHC's Flyrcado gains momentum with FDA approval, CMS support, and expanding coverage in cardiac PET imaging.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Philips Q1 Earnings Miss: Will Weak Outlook Drag the Stock Down?
by Zacks Equity Research
PHG's first-quarter results reflect a decline in sales and earnings due to weaker demand in China, leading to lowered 2025 guidance and a cautious outlook.
Why Royal Philips (PHG) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
PHG Expands Enterprise Imaging in EU: Buy, Sell or Hold the Stock?
by Zacks Equity Research
Philips expands cloud-based imaging in Europe, enhancing AI-driven workflows, collaboration and efficiency in radiology.
Philips Q4 Earnings Miss: Will Weak Outlook Drag the Stock Down?
by Zacks Equity Research
PHG's fourth-quarter results reflect a decline in sales and earnings due to weaker demand in China, leading to lowered 2025 guidance and a cautious outlook.
Amazon Rises 45.6% in 2024: Will AWS & AI Innovation Fuel 2025 Rally?
by Vasundhara Sawalka
Amazon soars 45.6% in 2024, powered by AWS & AI. Strong financials and market innovation make AMZN worth buying for 2025 investors seeking tech growth.
Bio-Rad (BIO) Down 5.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Bio-Rad (BIO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Philips Q3 Earnings Beat: Will Weak Outlook Drag the Stock Down?
by Zacks Equity Research
PHG's third-quarter results reflect improved earnings but highlight challenges with declining sales in China and growth in other regions, showcasing mixed performance.
Down -18.64% in 4 Weeks, Here's Why Philips (PHG) Looks Ripe for a Turnaround
by Zacks Equity Research
Philips (PHG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
PHG vs. RMD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PHG vs. RMD: Which Stock Is the Better Value Option?
Are Investors Undervaluing Koninklijke Philips (PHG) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Royal Philips (PHG) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
PHG or RMD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PHG vs. RMD: Which Stock Is the Better Value Option?
Should Value Investors Buy Koninklijke Philips (PHG) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Royal Philips (PHG) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Royal Philips (PHG) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You Looking for a Top Momentum Pick? Why Royal Philips (PHG) is a Great Choice
by Zacks Equity Research
Does Royal Philips (PHG) have what it takes to be a top stock pick for momentum investors? Let's find out.
PetIQ, Inc. (PETQ) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
PetIQ (PETQ) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
PHG vs. ESLOY: Which Stock Is the Better Value Option?
by Zacks Equity Research
PHG vs. ESLOY: Which Stock Is the Better Value Option?